Klaus Warnatz
Papers
1
Total Citations
19
H-Index
1
About
Klaus Warnatz is a leading immunologist whose research focuses on the pathogenesis and clinical management of primary immunodeficiencies, particularly Common Variable Immunodeficiency (CVID). His major contributions have centered on unraveling the cellular and molecular mechanisms underlying immune dysregulation in CVID, including the identification of distinct T-cell abnormalities that drive disease progression. Notably, his work on the "Exhausted phenotype of follicular CD8 T cells in CVID" (2020, 19 citations) has provided critical insights into how chronic antigenic stimulation leads to T-cell exhaustion, offering new targets for therapeutic intervention. Warnatz’s research has significantly advanced the understanding of B-cell and T-cell interactions in immunodeficiency, with his studies frequently cited for their translational relevance. He has also been instrumental in defining clinical phenotypes and biomarkers that guide personalized treatment strategies for patients with CVID, earning him recognition as a key figure in the field. His contributions continue to shape both basic immunology and clinical practice, making his work essential reading for researchers and clinicians alike.
Research Focus
Key Achievements
Top Papers
- 1Exhausted phenotype of follicular CD8 T cells in CVID19 citations · 2020